If a patient is given atropine for bradycardia and becomes agitated, what is the recommended treatment?

If a patient is given atropine for bradycardia and becomes agitated, what is the recommended treatment?

• A. Physostigmine
• B. Flumazenil
• C. Activated Charcoal
• D. Propofol

Answer: (A)

Atropine is an anticholinergic agent commonly used to treat bradycardia by increasing heart rate. However, it can also cause central nervous system side effects, including agitation, confusion, and delirium, particularly in sensitive populations or at higher doses. In the case of a patient who has become agitated after receiving atropine, the most appropriate treatment is physostigmine. Physostigmine is a reversible inhibitor of the enzyme acetylcholinesterase, which leads to an increase in acetylcholine levels in the central nervous system. By increasing acetylcholine, it can counteract the central effects of atropine, effectively mitigating symptoms like agitation and confusion. This makes physostigmine particularly useful in cases of anticholinergic toxicity. The other options do not address the underlying issue caused by atropine. Flumazenil is a benzodiazepine antagonist and would not be effective since the agitation is not due to benzodiazepine use. Activated charcoal may be considered for decontamination in cases of ingestion but is not directly beneficial for managing agitation related to atropine. Propofol is a sedative and might alleviate agitation, but it does not treat the underlying cause of the symptoms related to the ant

Atropine is an anticholinergic agent commonly used to treat bradycardia by increasing heart rate. However, it can also cause central nervous system side effects, including agitation, confusion, and delirium, particularly in sensitive populations or at higher doses. In the case of a patient who has become agitated after receiving atropine, the most appropriate treatment is physostigmine.

Physostigmine is a reversible inhibitor of the enzyme acetylcholinesterase, which leads to an increase in acetylcholine levels in the central nervous system. By increasing acetylcholine, it can counteract the central effects of atropine, effectively mitigating symptoms like agitation and confusion. This makes physostigmine particularly useful in cases of anticholinergic toxicity.

The other options do not address the underlying issue caused by atropine. Flumazenil is a benzodiazepine antagonist and would not be effective since the agitation is not due to benzodiazepine use. Activated charcoal may be considered for decontamination in cases of ingestion but is not directly beneficial for managing agitation related to atropine. Propofol is a sedative and might alleviate agitation, but it does not treat the underlying cause of the symptoms related to the ant